Telmisartan 1-O-acylglucuronide, the principal metabolite of telmisartan in
humans, was characterized in terms of chemical stability and the structure
of its isomerization products was elucidated. In addition, pharmacokinetic
s of telmisartan 1-O-acylglucuronide were assessed in rats after i.v. dosin
g. Similar to other acylglucuronides, telmisartan 1-O-acylglucuronide and d
iclofenac 1-O-acylglucuronide, which was used for comparison, showed the fo
rmation of different isomeric acylglucuronides on incubation in aqueous buf
fer. The isomeric acylglucuronides of telmisartan consisted of the 2-O-, 3-
O-, and 4-O-acylglucuronides (alpha,beta-anomers). First order degradation
half-lives of 26 and 0.5 h were observed on incubation in buffer of pH 7.4
for the 1-O-acylglucuronides of telmisartan and diclofenac, respectively. T
his indicated that the 1-O-acylglucuronide of telmisartan was among the mos
t stable acylglucuronides reported to date. The high stability of telmisart
an 1-O-acylglucuronide was confirmed by in vitro experiments that indicated
only very low covalent binding of telmisartan acylglucuronide to human ser
um albumin but a considerable amount of covalently bound radioactivity with
the acylglucuronide of diclofenac. After i.v. dosing to rats, telmisartan
1-O-acylglucuronide was rapidly cleared from plasma with a clearance of 180
ml/min/kg, compared with 15.6 ml/min/kg for the parent compound. Because t
elmisartan 1-O-acylglucuronide exhibited a comparably high chemical stabili
ty together with a high clearance that resulted in low systemic exposure, t
he amount of covalent binding to proteins should be negligible compared wit
h other frequently used drugs, such as furosemide, ibuprofen, or salicylic
acid.